Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 Oct;79(10):874-7.
doi: 10.1136/bjo.79.10.874.

Onset and recurrence of proliferative vitreoretinopathy in various vitreoretinal disease

Affiliations

Onset and recurrence of proliferative vitreoretinopathy in various vitreoretinal disease

H Mietz et al. Br J Ophthalmol. 1995 Oct.

Abstract

Aims: This study aimed to evaluate both the mean time intervals between retinal disease and the development of proliferative vitreoretinopathy (PVR) and the time intervals at which recurrent PVR develops following various kinds of vitreoretinal disease and surgery.

Methods: One hundred and thirty six consecutive cases of PVR that were seen and operated on between 1991 and 1994 were evaluated retrospectively. Intervals between onset of disease and PVR or recurrent PVR were noted. Conditions leading to PVR, surgical procedures, and the final anatomical and functional results were evaluated.

Results: Before PVR was noted for the first time, an average of 1.06 vitreoretinal surgical procedures were performed (range 0 to 3). A mean of 1.99 surgeries were performed to control PVR or to reach an end stage where further surgery would have been unreasonable (range 0 to 5). The average (median) time interval between the onset of the retinal disease and PVR was 2.0 months (range 0.5 to 45 months). The median time intervals between surgery and recurrence for the second, third, or fourth times was also 2.0 months (range 0.5 to 34 months).

Conclusions: PVR starts earliest at 2 weeks after an event and subsequently quietens down within a maximum of 45 months after treatment (median 2 months). PVR may recur more than once but the time course of the disease is likely to be the same for each recurrence.

PubMed Disclaimer

Comment in

  • Proliferative vitreoretinopathy.
    Leaver PK. Leaver PK. Br J Ophthalmol. 1995 Oct;79(10):871-2. doi: 10.1136/bjo.79.10.871. Br J Ophthalmol. 1995. PMID: 7488570 Free PMC article. Review. No abstract available.

References

    1. Graefes Arch Clin Exp Ophthalmol. 1991;229(2):150-2 - PubMed
    1. Ophthalmology. 1989 Jun;96(6):811-20; discussion 821 - PubMed
    1. Fortschr Ophthalmol. 1991;88(3):219-24 - PubMed
    1. Surv Ophthalmol. 1992 Mar-Apr;36(5):373-84 - PubMed
    1. Am J Ophthalmol. 1992 Sep 15;114(3):257-79 - PubMed